Amedisys (AMED) PT Raised to $133 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Amedisys (AMED) PT Raised to $136 at UBS
March 1, 2019 6:58 AM ESTUBS raised its price target on Amedisys (NASDAQ: AMED) to $136.00 (from $126.00) while maintaining a Neutral rating.
... MoreAmedisys (AMED) PT Raised to $140 at Oppenheimer
February 28, 2019 4:17 PM ESTOppenheimer analyst Michael Wiederhorn raised the price target on Amedisys (NASDAQ: AMED) to $140.00 (from $137.00) while maintaining a Outperform rating.
... MoreAmedisys (AMED) PT Lowered to $124 at Craig-Hallum
February 28, 2019 3:52 PM ESTCraig-Hallum analyst Kevin Ellich lowered the price target on Amedisys (NASDAQ: AMED) to $124.00 (from $132.00) while maintaining a Hold rating.
Ellich notes FY19 guidance was lower partially due to CCH integration.
... More